Berezina, T.A.; Berezin, O.O.; Hoppe, U.C.; Lichtenauer, M.; Berezin, A.E.
Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial Infarction. Biomedicines 2024, 12, 1857.
https://doi.org/10.3390/biomedicines12081857
AMA Style
Berezina TA, Berezin OO, Hoppe UC, Lichtenauer M, Berezin AE.
Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial Infarction. Biomedicines. 2024; 12(8):1857.
https://doi.org/10.3390/biomedicines12081857
Chicago/Turabian Style
Berezina, Tetiana A., Oleksandr O. Berezin, Uta C. Hoppe, Michael Lichtenauer, and Alexander E. Berezin.
2024. "Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial Infarction" Biomedicines 12, no. 8: 1857.
https://doi.org/10.3390/biomedicines12081857
APA Style
Berezina, T. A., Berezin, O. O., Hoppe, U. C., Lichtenauer, M., & Berezin, A. E.
(2024). Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial Infarction. Biomedicines, 12(8), 1857.
https://doi.org/10.3390/biomedicines12081857